2-acetylaminofluorene has been researched along with Cancer of Testis in 2 studies
2-Acetylaminofluorene: A hepatic carcinogen whose mechanism of activation involves N-hydroxylation to the aryl hydroxamic acid followed by enzymatic sulfonation to sulfoxyfluorenylacetamide. It is used to study the carcinogenicity and mutagenicity of aromatic amines.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cabral, JR | 1 |
| Neal, GE | 1 |
| Cheo, DL | 1 |
| Burns, DK | 1 |
| Meira, LB | 1 |
| Houle, JF | 1 |
| Friedberg, EC | 1 |
2 other studies available for 2-acetylaminofluorene and Cancer of Testis
| Article | Year |
|---|---|
Testicular mesotheliomas in rats exposed to N-2-fluorenylacetamide (FAA).
Topics: 2-Acetylaminofluorene; Animals; Male; Mesothelioma; Neoplasms, Experimental; Rats; Rats, Inbred F344 | 1983 |
Mutational inactivation of the xeroderma pigmentosum group C gene confers predisposition to 2-acetylaminofluorene-induced liver and lung cancer and to spontaneous testicular cancer in Trp53-/- mice.
Topics: 2-Acetylaminofluorene; Animals; DNA Repair; Female; Genes, p53; Humans; Liver Neoplasms, Experimenta | 1999 |